UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition

Cellular physiology and biochemistry, 2016-01, Vol.39 (5), p.1863-1876

2016

Volltextzugriff (PDF)

The Molecular Effects of Ionizing Radiations on Brain Cells: Radiation Necrosis vs. Tumor Recurrence

Diagnostics (Basel), 2019-09, Vol.9 (4), p.127

2019

Volltextzugriff (PDF)

Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro

Cancer biology & therapy, 2014-06, Vol.15 (6), p.797-805

2014

Volltextzugriff (PDF)

FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920947970-1758835920947970

2020

Volltextzugriff (PDF)

Enhancement of Antitumor Activity of Ionizing Radiation by Combined Treatment with the Selective Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

Clinical cancer research, 2002-10, Vol.8 (10), p.3250-3258

2002

Volltextzugriff (PDF)

Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report

Journal of medical case reports, 2017-09, Vol.11 (1), p.273-273, Article 273

2017

Volltextzugriff (PDF)

Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma

Clinical cancer research, 2005-08, Vol.11 (15), p.5639-5644

2005

Volltextzugriff (PDF)

EP-1083: Usefulness of PET/CT in definition of treatment volumes of head and neck tumors

Radiotherapy and oncology, 2016-04, Vol.119, p.S520-S521

2016

Volltextzugriff (PDF)

The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells

Cellular physiology and biochemistry, 2017, Vol.43 (1), p.108-119

2017

Volltextzugriff (PDF)

Antitumor Activity of Combined Treatment of Human Cancer Cells with Ionizing Radiation and Anti-Epidermal Growth Factor Receptor Monoclonal Antibody C225 plus Type I Protein Kinase A Antisense Oligonucleotide

Clinical cancer research, 2000-11, Vol.6 (11), p.4343-4350

2000

Volltextzugriff (PDF)

Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer

Clinical cancer research, 2006-12, Vol.12 (23), p.7099-7107

2006

Volltextzugriff (PDF)

The current status of novel PET radio-pharmaceuticals in radiotherapy treatment planning of glioma

Current pharmaceutical biotechnology, 2014, Vol.14 (13), p.1099-1104

2014

Volltextzugriff (PDF)

Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model

Molecular cancer therapeutics, 2004-08, Vol.3 (8), p.977-983

2004

Volltextzugriff (PDF)

Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents

Journal of clinical medicine, 2020-03, Vol.9 (3), p.675

2020

Volltextzugriff (PDF)

Tumour Microenvironment and Immune Evasion in EGFR Addicted NSCLC: Hurdles and Possibilities

Cancers, 2019-09, Vol.11 (10), p.1419

2019

Volltextzugriff (PDF)

Mechanisms of resistance to mTOR inhibitors

Critical reviews in oncology/hematology, 2020-03, Vol.147, p.102886-102886, Article 102886

2020

Volltextzugriff (PDF)

SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation

Scientific reports, 2017-03, Vol.7 (1), p.45361-45361, Article 45361

2017

Volltextzugriff (PDF)

SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells

Oncotarget, 2016-03, Vol.7 (13), p.15868-15884

2016

Volltextzugriff (PDF)

Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy

Oncotarget, 2015-11, Vol.6 (35), p.37511-37525

2015

Volltextzugriff (PDF)

External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of life

Oncology reports, 2003-03, Vol.10 (2), p.399

2003

Volltextzugriff (PDF)

In Silico Identification and Biological Evaluation of Novel Selective Serum/Glucocorticoid-Inducible Kinase 1 Inhibitors Based on the Pyrazolo-Pyrimidine Scaffold

Journal of chemical information and modeling, 2014-07, Vol.54 (7), p.1828-1832

2014

Volltextzugriff (PDF)

The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64 CuCl 2 in Human Glioblastoma Multiforme Cells

Cellular physiology and biochemistry, 2017-10, Vol.43 (1), p.108-119

2017

Volltextzugriff (PDF)

Repeat stereotactic radiosurgery in the management of brain metastases from NSCLC: A case report and review of the literature

Oncology letters, 2013-10, Vol.6 (4), p.897-900

2013

Volltextzugriff (PDF)

ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapy

International journal of radiation oncology, biology, physics, 2006, Vol.64 (1), p.33-37

2006

Volltextzugriff (PDF)

ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapy

International journal of radiation oncology, biology, physics, 2006-01, Vol.64 (1)

2006

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(47)
Buchkapitel
(2)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(33)
Humans
(24)
Oncology
(18)
Female
(12)
Animals
(10)
Tumors
(9)
Radiotherapy
(8)
Biological And Medical Sciences
(7)
Cell Line, Tumor
(7)
Mice
(7)
Apoptosis
(6)
Kinases
(6)
Medical Sciences
(6)
Cancer Therapies
(5)
Phosphorylation
(5)
Protein-Serine-Threonine Kinases - Antagonists & Inhibitors
(5)
Signal Transduction - Drug Effects
(5)
Aged
(4)
Angiogenesis
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition

The Molecular Effects of Ionizing Radiations on Brain Cells: Radiation Necrosis vs. Tumor Recurrence

Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro

FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules

Enhancement of Antitumor Activity of Ionizing Radiation by Combined Treatment with the Selective Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report

Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in Glioblastoma

EP-1083: Usefulness of PET/CT in definition of treatment volumes of head and neck tumors

The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells

Antitumor Activity of Combined Treatment of Human Cancer Cells with Ionizing Radiation and Anti-Epidermal Growth Factor Receptor Monoclonal Antibody C225 plus Type I Protein Kinase A Antisense Oligonucleotide

Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer

The current status of novel PET radio-pharmaceuticals in radiotherapy treatment planning of glioma

Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model

Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents

Tumour Microenvironment and Immune Evasion in EGFR Addicted NSCLC: Hurdles and Possibilities

Mechanisms of resistance to mTOR inhibitors

SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation

SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells

Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy

External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of life

In Silico Identification and Biological Evaluation of Novel Selective Serum/Glucocorticoid-Inducible Kinase 1 Inhibitors Based on the Pyrazolo-Pyrimidine Scaffold

The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64 CuCl 2 in Human Glioblastoma Multiforme Cells

Repeat stereotactic radiosurgery in the management of brain metastases from NSCLC: A case report and review of the literature

ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapy

ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapy

Suchergebnisse filtern